Abstract:
Background -Inducible Ventricular tachycardia (VT) is a strong predictor of spontaneous ventricular tachyarrhythmia following ST elevation myocardial infarction (STEMI). Reduced left ventricular ejection fraction (LVEF) predisposes patients to inducible ventricular tachycardia post STEMI. However the role of right ventricular (RV) dysfunction in predisposing to inducible VT has not been described previously.
Methods and Results -Consecutive patients with STEMI treated with primary percutaneous coronary intervention (PPCI) underwent pre-discharge radionuclide gated heart pool scan (GHPS) to assess ventricular ejection fraction (EF). The study cohort included patients with underwent electrophysiology study (EPS) (n=220) in an attempt to induce VT. We defined RV dysfunction as right ventricular ejection fraction (RVEF)
The end point was sustained monomorphic VT (Cycle length CL This was considered a positive study. No inducible arrhythmia, ventricular fibrillation or flutter (CL<200ms) was considered a negative study. Infarct region, infarct related artery, male gender %, were univariable predictors of positive test. After multivariable analysis, strongest association as an independent predictor of inducible VT at EPS (p<0.001, OR 5.8; 95% CI, 3.005 to 11.262).
Conclusions -RV dysfunction ( ) predisposed to inducible VT at EPS in patients
with impaired LVEF ( after acute STEMI treated with primary PCI.
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Background
Ventricular arrhythmias remain an important cause of mortality in survivors of acute myocardial infarction (AMI). The rate of death including sudden cardiac death (SCD) remains highest in the first few weeks after STEMI 1, 2 . Identification of those at risk for arrhythmic death amongst survivors of AMI is a challenging problem 3, 4 .
After AMI, the infarct zone goes through series of stages with replacement of dead myocardium by collagenized scar tissue 5 . Late remodelling involves myocyte hypertrophy and dense collagen scar formation. The collagen fibers disposition parallels that of infarcted myocardial fibers mirroring the anisotropic structure of myocardium 6 . VT usually arises from these reentrant circuit that incorporates areas of adipose metaplasia 7 and scarred myocardium with surrounding normal myocardium 8 . While the myocardial scar composition does change with time there is some evidence that the associated re-entrant circuit and associated substrate of VT stabilizes within the first week post-MI 9 . The electroanatomic and electrophysiologic characteristics of inducible VT in subacute and chronic phase after AMI have been shown to be similar in an ovine model. This suggests that VT re-entrant circuits form early post infarct.
EPS can demonstrate the presence of an electrical substrate for re-entrant VT and consistently predicts arrhythmic risk in observational and randomised studies 10, 11 . Inducible VT at EPS in patients with left ventricular dysfunction post-MI is predictive of spontaneous ventricular arrhythmia [12] [13] [14] [15] .
Reduced left ventricular ejection fraction (LVEF) is associated with increased risk of ventricular tachyarrhythmia 16 . Optimal use of prognostic electrophysiology testing is achieved by usin 40% as a preselector in infarct survivors 17 . Survivors of STEMI with RV myocardial involvement have a worse prognosis than those who do not have RV involvement tics of ind cible VT in s bac te and chronic phase after AMI ha e been sho n t ran n nt t t ci ci circ r rcui ui uit t t that at at incorporates areas of adi i ipo po p se metaplasi ia 7 an an and scarred myocardiu un n nd d ding normal l m myoc o ocardi di diu u um 8 8 8 . 19 . It is unclear if this is associated with increased arrhythmic risk. The role of RV dysfunction in predisposing to inducible VT has not been described previously. The purpose of the present study was to examine if RV dysfunction early after STEMI was associated with VT inducibility in patients with at least moderate LV dysfunction at EPS.
Methods

Study Population
Consecutive patients with STEMI treated with PPCI at a single tertiary centre from 2006 to 2012 were recruited. The study was approved by the Institutional review committee and the subjects gave their written informed consent. Patients presented directly to the primary percutaneous intervention centre, Westmead Hospital or were referred by three associated district hospitals.
All patients in the study had angiographically confirmed coronary artery occlusion responsible for STEMI. STEMI was defined as the presence of typical chest pain and accompanying symptoms for duration of at least 30 minutes but less than 12 hours in the presence of STsegment . Patients who underwent PPCI for LBBB, presumed new or undetermined duration; were not included. No patient received thrombolytic therapy because of the well established PPCI service at our hospital.
Patients were excluded if they were age <18 or > 85 years, underwent pre-discharge coronary artery bypass surgery (CABG), died prior to discharge from hospital or had ventricular ejection fraction estimated by transthoracic echocardiogram (TTE) only.
Following early revascularization, patients were commenced on optimal medical therapy including Aspirin, 2 nd antiplatelet agent (Clopidogrel or Prasurgrel) Beta-blocker (except sotalol), Angiotentison convering enzyme inhibitor (or Angiotensin receptor blocker) and statin. s i i in n n n th th the e e e st st st stud ud ud udy y y y ha ha ha ad d d d an an an angi g g g og g g gra ra raph ph ph phi i i ical al al lly ly ly y co co co conf nf nf nfir ir ir i me me me med d d d co co co oro ro ro rona na na n ry ry ry ry a a art rt rt r er er ery y y y oc oc oc ccl cl cl c us us us usio io io i n n n n re e e esp sp sp spon on on ns I. ST T T TEM EM EM E I I I wa wa was s s de de de defi fi fi f ne ne ned d d as as as t t the he he h p p pre r re rese se senc nc nc ce e e of f f f t t typ yp ypic ic ic ical al al al c c c che he he h st st st t p pai ai ai a n n n an an an nd d d d ac ac ac a co co co omp mp mp pan an an a yi yi yi y ng ng ng ng for o d dur u at atio io io i n of of f f a at t t t le l le l as a ast t t t 30 30 3 min i in inut t ut utes es b b b but ut ut t l l le ess ss t t t th ha ha h n 12 12 12 2 h h h hou ours s i i i in th th th he e pr p es esen e ce ce o of ST S -
Assessment of Ventricular Function
The study protocol required assessment of ventricular EF hours after PPCI with planar equilibrium radionuclide ventriculography. Radionuclide angiography was performed at rest in the supine position after "in-vivtro" red cell labelling. Following 0.7 mg stannous pyrophosphate IV, 4 ml of heparinised autologous blood was labelled with 99mTc pertechnetate, and injected intravenously. Dynamic first pass (40x2 sec 64x64 matrix) in the RAO projection, and 16 bin zoomed gated images in MLAO, anterior and left lateral projections were acquired. A region of interest was precisely assigned to ventricular blood pool on the equilibrium gated images. To correct for activity originating from non-cardiac background structures, background region of interest was also assigned. Global ventricular EF was computed from composite timeactivity curves using a computer algorithm incorporating background correction.
Electrophysiology Study
Patients with LVEF >40% were discharged; -discharge EPS to assess risk of future spontaneous ventricular tachyarrhythmia. Reduced RVEF was not considered an indication for EPS.
All subjects gave informed written consent. Intravenous sedation using midazolam and fentanyl was used. Antiarrhythmic medications were avoided for at least 1 week prior to EPS when possible. Standard beta blocker therapy (except sotalol) was not interrupted. Programmed ventricular stimulation to induce VT was performed with a quadpolar catheter deployed in the right ventricular apex. Our institutional protocol for post-infarct EPS has been described previously 15, 20 . A drive train (S1S1) of 8 beats at 400 ms was followed by up to four extrastimuli (ES) delivered one at a time. Our lab has previously published data supporting the role of upto 4 ES in an attempt to induce VT 20 . Stimuli were rectangular pulses of 2 ms duration the equ q ilibrium g gat at at ated ed e e nd st t tru ruct t ctur ures es, ba ba b b ck ck ck ckg g gr gro nterest was also assigned. Global ventricular EF was computed from composite t r y i c ess risk of f t re spontaneo s entric lar tach arrh thmia Red ced RVEF as nte e e ere re re rest s st s w w was as as a als s so o o o assigned. Global ventric c c cul ul ul la ar EF was co o omp p put ut ut u ed from composite t rve ve ve ves s using a co om mput u uter a a alg lg lg gorit t t thm hm hm h inco orp p por rat ting g g b b bac ac ac ack kgr ro rou und c corr rr rre ection n n n. Stimulation was repeated a second time from the same site, using the same protocol, if the initial induction was negative for VT. Isoprenaline infusion was not utilized to facilitate VT induction.
Additional stimulation from the RV outflow tract was not performed. If EPS was positive, preation was recommended. If EPS was negative, discharge without an ICD was recommended.
Statistical Methods
Continuous data are presented as either mean or median (lower-upper quartile). The categorical variables are presented as frequencies and percentage. The primary aim was to assess the association between the RVEF and inducible VT at electrophysiology study. ) wh wh h ho o we were e rec ecru uit te e Table 1 summarizes baseline demographics and angiographic characteristics of the study cohort according to their RVEF. Mean age of study cohort was 57 ± 11 years, and most patients were men (86%). The baseline variables in the two groups were similar. However, the median LVEF in group 1(biventricular dysfunction) was lower compared to group 2 (LV dysfunction only) (31%, range 27 -35 % versus 34%, range 29 to 37%; p=0.014).
Results
Ventricular
STEMI was complicated with pulmonary edema in 43 (20%) of patients. As expected, mean LVEF was lower in patients with pulmonary edema (29± 7 % versus 32 ±6 %, p=0.018), but there was no difference in RVEF between patients with and without pulmonary edema (38±13% versus 38 ±13%, p=0.857).
Majority of patients had presented with anterior / antero-lateral infarct (84%). Pulmonary edema was observed in 37 (20%) of patients with anterior / antero-lateral infarction.
RV dysfunction was observed in nearly a third of patients (n= 63, ie 34%) presenting with anterior / antero-lateral infarction. A small number of patients undergoing EPS had previous history of ischemic heart disease and percutaneous coronary intervention (PCI).
However there was no statistic significant difference between the two groups (i.e. Biventricular dysfunction Vs Isolated LV dysfunction). When we analysed the indications for PCI, more number of patients in preserved RVEF > 35%) had suffered prior myocardial infarction (STEMI and NSTEMI) (38% vs 17%) with culprit vessel stent deployed in LAD (86%). However due to small numbers, a statistic analysis could not be interpreted with confidence.
Inferior infarct was more likely associated with RV dysfunction (p=0.022) compared to When RCA was the culprit vessel patients were more likely to have lower mean RVEF compared to other coronary arteries (p=0.022). This is in keeping with prior observation that inferior infarct is often result of dominant RCA occlusion which is more likely to be associated with RV dysfunction.
Baseline TIMI flow was comparable between the two groups. Procedural success with TIMI III flow was similar in both groups (group 1: 96.25% Vs group 2: 96.42%) Table 2) RV dysfunction in anterior infarct (p<0.001), but not inferior infarct (p=0.579) was associated with VT inducibility (Table 3) . However, the Test of interaction between the effects of RVEF <35% and infarct region in those with LVEF <40% was not sig (p= 0.097). The power to detect significant interaction is low here because of small individuals with inferior infarct.
Results of programmed ventricular stimulation (
Multivariate analysis of predictors for inducible sustained VT:
Stepwise logistic regression was applied to the significant univariate predictors (Table 4) Through multivariate analysis we identified, RV dysfunction, infarct related artery (LAD) and infarct region were significantly associated with inducible VT. Previous studies have identified LAD disease and anterior segment wall motion (Table 4) 21 as predictors of VT inducibility at EPS. However, our data have identified strong and highly significant association between VT inducibility and presence of RV dysfunction (p<0.001). No other study has examined this association yet. Mehta et al in a metanalysis found that RV myocardial involvement in patients with acute inferior myocardial infarction had a 2.7x increase in the risk of spontaneous sustained ventricular tachycardia and ventricular fibrillation supporting our finding that infarcted RV may be potentially arrhythmogenic. Their study has shown that adverse outcomes in patients with RV myocardial involvement are not simply due to more extensive LV dysfunction but rather due to direct RV involvement. Our findings are also consistent with MUSTT, a large randomized clinical trial in which EPS was performed in patient % 22 . This suggests VT inducibility is more complex and not simply a function of degree of LV impairment. In our study we found presence of RV dysfunction was strongly predictive of inducible VT in cohort with moderate as well as more severe LV dysfunction, suggesting that RV impairment confers arrhythmogenicity at all degrees of LV impairment ( figure 3 ).
RV function has also been shown to have independent prognostic value in patients with LV dysfunction after AMI 23 . Preserved RVEF predicts exercise capacity and survival in advanced heart failure 24 . While the existing literature supports that patients with RV dysfunction 
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have increased mortality [25] [26] [27] , the mechanisms underlying this are not very clear. It is not clear if increased mortality is a result of progressive pump failure or increased incidence of ventricular arrhythmias. Our study has shown presence of underlying arrhythmogenic substrate is more common in presence of biventricular dysfunction compared to isolated LV systolic dysfunction.
In survivors of AMI, ventricular arrhythmia remains an important cause of SCD.
Strategies for primary prevention of SCD in this cohort remain imperfect. The current guidelines for implantation of ICD for primary prevention of SCD after myocardial infarction are based solely on LVEF 28 . According to one report nearly 37% of patients after experiencing myocardial infarction will meet the 2006 ACC/AHA/ESC criteria for implantation of ICD for primary prevention of SCD 29 . Despite guideline recommendation widespread use of AICD is not generally practised, primarily because of the cost of therapy and associated morbidity. Judicious use of ICD in these patients is justified as sensitivity and specificity of LVEF in isolation to predict risk of SCD is limited 30 . While it is clear that a subgroup of STEMI patients with LV dysfunction remains at high risk of arrhythmic complications after STEMI, we are limited by not being able to accurately identify them. This necessitates further efforts to better risk stratify patients after AMI 31 . We feel that adding RVEF assessment to the equation may help identify particularly vulnerable patients who may benefit from primary prevention strategies. However, more work needs to be done in this area and there is a need for longitudinal study assessing incidence of spontaneous arrhythmia in the patients with RV dysfunction in addition to LV dysfunction.
During our study, we found more extrastimuli were required to induce VT in patients with biventricular dysfunction compared to those with preserved RV and impaired LV dysfunction We found an interesting propensity for LBBB morphology VT in patients with RV dysfunction in addition to left ventricular dysfunction, when compared to those with isolated LV dysfunction (50% versus 35%). This difference was not statistically significant probably because our study cohort was too small. VT of LBBB morphology usually suggests origin of VT from the interventricular septum or right ventricular free wall. Based on our observation we hypothesize that VT induced in patients with RV dysfunction from STEMI has a greater possibility of originating from the RV free wall or more likely interventricular septum, compared to patients without significant RV dysfunction. However we did not undertake detailed mapping of the VT during the EPS to confirm this hypothesis.
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Another interesting clinical observation was high incidence of RV dysfunction (34%) in patients with anterior infarcts and LV dysfunction. MRI studies have found similar high incidence of RV involvement in AMI. Jensen and colleagues 32 performed cardiac MRI at mean of 2.9 days after primary PCI for acute myocardial infarction. According to their MRI criteria RV involvement was present in 65% of patients with anterior myocardial infarction. TTE failed to identify RV involvement in 77% of anterior myocardial infarction, implying that RV dysfunction is perhaps more commoner in anterior infarcts than generally appreciated. It might in pa p tients with RV RV RV RV d to th th th thos ose e wi i wi ith th th th i iso o o ola la la lat te te n (50% versus 35%). This difference was not statistically significant probably be cohort was too small. VT of LBBB mor ology usually suggests ori n of VT fro and impaired septal contractility with consequential RV dysfunction 32 . One alternative mechanism could be, depressed RV function simply due to mechanical reasons secondary to increased afterload after LV dysfunction from anterior infarction 33 . While elevated pulmonary pressures does remain a logical explanation animal models have shown this is not essential 34 .
Limitations
Data was obtained from a single-centre observational study, but was collected prospectively. We undergoing EPS and hence cannot comment (>40%). We have not yet analysed clinical outcomes and hence cannot determine from this data whether inducible VT in patients with RV dysfunction is related to arrhythmia risk. We used radionuclide derived ejection fraction for assessing RV function. The gold standard for measurement of RVEF is probably cardiac MRI. However this technique is limited by cost, availability and technical difficulties (claustrophobic patients, breath holding, good heart rate control and prolonged procedural times).
By comparison gated blood scan is inexpensive, widely available and well tolerated by patients.
While transthoracic echocardiography (TTE) is the most widely available technique, an accurate estimate of RVEF is difficult often due to poor windows and inability to define the endocardial borders accurately. The accuracy of radionuclide parameters in assessing RVEF is somewhat intermediate between MRI and TTE. Despite inherent limitations, radionuclide RVEF continues hile elevated p pulmo mo mo mon n n thi i is s is i i is n n t ot ot t e ess ssen n n nti ti ti tia a al al pital f f for or or or t t t the he he heir ir ir ir t t t tre re re reme me me mend n n r f s r th th th his is is is study y y. 
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